MIRA Pharmaceuticals, Inc. (MIRA) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师预估 每股收益(EPS)为 $-0.55 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.51 vs 预期 $-0.55 (超预期 +7.8%). 2025: 实际 $-1.35 vs 预期 $-1.17 (不及预期 -15.4%). 分析师准确度: 89%.
MIRA 分析师评级
Buy
基于过去3个月内 2 位分析师对 MIRA Pharmaceuticals, Inc. 的评级
EPS 预测 — MIRA
89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.51
vs Est –$0.55
▲ 8.5% off
2025
Actual –$1.35
vs Est –$1.17
▼ 13.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — MIRA
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
